These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Study of the use of axial viewed inductively coupled plasma atomic emission spectrometry with ultrasonic nebulization for the determination of select elemental impurities in oral drug products. Menoutis J; Parisi A; Verma N J Pharm Biomed Anal; 2018 Apr; 152():12-16. PubMed ID: 29414002 [TBL] [Abstract][Full Text] [Related]
3. An Elemental Impurities Excipient Database: A Viable Tool for ICH Q3D Drug Product Risk Assessment. Boetzel R; Ceszlak A; Day C; Drumm P; Gil Bejar J; Glennon J; Harris L; Heghes CI; Horga R; Jacobs PL; Keurentjes WJTM; King F; Lee CW; Lewen N; Marchant CA; Maris FA; Nye W; Powell S; Rockstroh H; Rutter L; Schweitzer M; Shannon E; Smallshaw L; Teasdale A; Thompson S; Wilkinson D J Pharm Sci; 2018 Sep; 107(9):2335-2340. PubMed ID: 29679706 [TBL] [Abstract][Full Text] [Related]
4. ICH Q3D based elemental impurities study in liquid pharmaceutical dosage form with high daily intake - comparative analysis by ICP-OES and ICP-MS. Janchevska K; Stafilov T; Memed-Sejfulah S; Bogdanoska M; Ugarkovic S; Petrushevski G Drug Dev Ind Pharm; 2020 Mar; 46(3):456-461. PubMed ID: 31999195 [TBL] [Abstract][Full Text] [Related]
5. Elemental impurities in pharmaceutical products adding fuel to the fire. Maithani M; Raturi R; Sharma P; Gupta V; Bansal P Regul Toxicol Pharmacol; 2019 Nov; 108():104435. PubMed ID: 31376414 [TBL] [Abstract][Full Text] [Related]
6. Flow injection combined with ICP-MS for accurate high throughput analysis of elemental impurities in pharmaceutical products according to USP <232>/<233>. Fischer L; Zipfel B; Koellensperger G; Kovac J; Bilz S; Kunkel A; Venzago C; Hann S J Pharm Biomed Anal; 2014 Jul; 95():121-9. PubMed ID: 24667566 [TBL] [Abstract][Full Text] [Related]
7. A direct LA-ICP-MS screening of elemental impurities in pharmaceutical products in compliance with USP and ICH-Q3D. Pluháček T; Ručka M; Maier V Anal Chim Acta; 2019 Oct; 1078():1-7. PubMed ID: 31358206 [TBL] [Abstract][Full Text] [Related]
8. Determination of ICH-Q3D Elemental Impurity Leachables in Glass Vials by Inductively Coupled Plasma Mass Spectrometry. Breckenridge L; Oni Y; Evans C; Franck J; Wood S; Xu M; Sahin E; Zacour B PDA J Pharm Sci Technol; 2023; 77(3):197-210. PubMed ID: 36241213 [TBL] [Abstract][Full Text] [Related]
9. Assessment of Extractable Elements from Elastomers. Paskiet D; Kraft C; Tullo E; Hunter J; Zurbriggen D PDA J Pharm Sci Technol; 2019; 73(1):83-91. PubMed ID: 30030347 [TBL] [Abstract][Full Text] [Related]
10. Clean Chemistry for Elemental Impurities Analysis of Pharmaceuticals in Compliance with USP 232. Jin C AAPS PharmSciTech; 2016 Oct; 17(5):1141-9. PubMed ID: 26586536 [TBL] [Abstract][Full Text] [Related]
11. A Risk-Based Approach to Evaluate and Control Elemental Impurities in Therapeutic Proteins. Luo Y; Sekhar C; Lee H; Fujimori K; Ronk M; Semin D; Nashed-Samuel Y J Pharm Sci; 2020 Nov; 109(11):3378-3385. PubMed ID: 32745562 [TBL] [Abstract][Full Text] [Related]
12. [The modern approaches to the determination of the content of elemental impurities in the pharmaceutical substances with the use of inductively-coupled plasma mass-spectrometry]. Bol'shov MA; Seregina IF; Uspenskaya EV; Titorovich OV; Syroeshkin AV; Maksimova TV; Pletneva TV Sud Med Ekspert; 2015; 58(6):31-33. PubMed ID: 26856057 [TBL] [Abstract][Full Text] [Related]
13. ICH Q3D Drug Product Elemental Risk Assessment: The Use of An Elemental Impurities Excipients Database. Torres S; Boetzel R; Gatimu E; Gomes DZ; King F; Kocks G; Jones R; Day C; Lewen N; Harris L; Teasdale A J Pharm Sci; 2022 May; 111(5):1421-1428. PubMed ID: 34673095 [TBL] [Abstract][Full Text] [Related]
14. Application of X-ray fluorescence spectrometry for screening pharmaceutical products for Elemental Impurities according to ICH guideline Q3D. Sauer B; Xiao Y; Zoontjes M; Kroll C J Pharm Biomed Anal; 2020 Feb; 179():113005. PubMed ID: 31812806 [TBL] [Abstract][Full Text] [Related]
15. Study and determination of elemental impurities by ICP-MS in active pharmaceutical ingredients using single reaction chamber digestion in compliance with USP requirements. Muller AL; Oliveira JS; Mello PA; Muller EI; Flores EM Talanta; 2015 May; 136():161-9. PubMed ID: 25702998 [TBL] [Abstract][Full Text] [Related]
16. Method for determination of elemental impurities in metronidazole benzoate using inductively coupled plasma mass spectrometry. Tian M; Zhang H; Fan H; Yin M; Wang W; Shi C Eur J Mass Spectrom (Chichester); 2024 Feb; 30(1):60-64. PubMed ID: 37926973 [TBL] [Abstract][Full Text] [Related]
17. An overview of recent applications of inductively coupled plasma-mass spectrometry (ICP-MS) in determination of inorganic impurities in drugs and pharmaceuticals. Nageswara Rao R; Talluri MV J Pharm Biomed Anal; 2007 Jan; 43(1):1-13. PubMed ID: 16891084 [TBL] [Abstract][Full Text] [Related]
18. Application of LA-ICP-MS as a rapid tool for analysis of elemental impurities in active pharmaceutical ingredients. Rudovica V; Viksna A; Actins A J Pharm Biomed Anal; 2014 Mar; 91():119-22. PubMed ID: 24440826 [TBL] [Abstract][Full Text] [Related]
19. Development and validation of a new HPLC-MS method for meglumine impurity profiling. Martano C; Ferretti F; Ghiani S; Buonsanti F; Bruno E; Lattuada L; Medana C J Pharm Biomed Anal; 2018 Feb; 149():517-524. PubMed ID: 29175747 [TBL] [Abstract][Full Text] [Related]
20. Microwave-assisted sample preparation of medicines for determination of elemental impurities in compliance with United States Pharmacopeia: How simple can it be? Pinheiro FC; Barros AI; Nóbrega JA Anal Chim Acta; 2019 Aug; 1065():1-11. PubMed ID: 31005141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]